Erol R. Akdamar - 12 Nov 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Reporting relationship: Group President
Issuer ticker: HCA
Reported as of: 12 Nov 2024
Net transaction value: -$3,239,886
SEC form: 4
Accepted by SEC: 14 Nov 2024, 18:50:10 UTC
Prior SEC filing: 13 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Kevin A. Ball, Attorney-in-Fact

Key filing fact

Erol R. Akdamar filed Form 4 for HCA Healthcare, Inc. (HCA) on 14 Nov 2024.

Key facts

This page summarizes Erol R. Akdamar's Form 4 filing for HCA Healthcare, Inc. (HCA).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Nov 2024, 18:50.

Change

Previous filing in this sequence was filed on 13 May 2024.
Current net transaction value: -$3,239,886.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Options Exercise

Transaction value: $1,379,200
Shares: +20,000
Change %
Price: $68.96
Shares after: 20,000
Date: 12 Nov 2024
Ownership: Direct

HCA transaction

Common Stock

Tax liability

Transaction value: $3,595,386
Shares: -10,257
Change %: -51%
Price: $350.53
Shares after: 9,743
Date: 12 Nov 2024
Ownership: Direct

HCA transaction

Common Stock

Sale

Transaction value: $1,023,700
Shares: -2,900
Change %: -30%
Price: $353.00
Shares after: 6,843
Date: 14 Nov 2024
Ownership: Direct

HCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 60,497
Date: 12 Nov 2024
Ownership: By Family Trust

HCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 60,000
Date: 12 Nov 2024
Ownership: By LLC

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCA transaction Derivative

Stock Appreciation Right

Options Exercise

Transaction value: $0
Shares: -20,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Nov 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $68.96
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .